CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The MATADOR project focuses on developing innovative cell-based assays to target the epithelial-to-mesenchymal transition in breast cancer. This approach aims to discover new drugs that can effectively treat metastatic breast cancer, addressing a significant gap in current treatment options.
Breast cancer is the most common cancer in women worldwide, with nearly 1.7 million new cases diagnosed in 2012.
Fortunately, the availability of diagnosis tools to detect mammary neoplastic tissues, as well as transcriptomic biomarkers helping for prognosis, and the diversity of treatment options for primary tumors allows a 90% 5-year survival rate.
However the metastatic grade of breast cancer is still not curable.Advances from basic research in the last decade outline the epithelial-to-mesenc…
COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
